PURPOSEThere is an increasing interest in studying the potential of mobile health (mHealth) technologies, such as smartphone apps and wearables, as monitoring tools for patients with cancer during or after their treatment. However, little research is …Patient-reported barriers and facilitators for mobile health use during cancer treatment.
Neoadjuvant chemotherapy followed by radical cystectomy is the standard treatment for cisplatin-eligible patients with muscle-invasive bladder cancer. Adding perioperative immunotherapy may improve…
Kenneth A. Bauer, MD Beth Israel Deaconess Medical Center Professor of Medicine Harvard Medical School A 39-year-old female has a history of bilateral pulmonary embolism…
Full data to be presented at 2024 American Society of Hematology Annual Meeting in December.
Recent radiologist compensation and clinical productivity trends have not been well characterized, especially across academic vs. non-academic practice settings.
He’s called Dr. Ed — that’s Edward T. Creagan, MD, a cancer specialist, the first Mayo Clinic doctor board certified in hospice and palliative medicine.…
Optimal first-line therapy for unresectable melanoma in-transit metastases has not been established, and options include isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesio…
Cheng Jiang 1*, Asadur Chowdury 1*, Xinhai Hou 1*, Akhil Kondepudi 1, Christian W. Freudiger 2, Kyle Conway 1, Sandra Camelo-Piragua 1, Daniel A. Orringer…
A new campaign from Fighting Knife Crime London is appealing to cut knife crime by calling for greater investment to prevent its root causes.
The OncoAlert Newsletter is now out for June 23-29, 2023
